News
Videos
Conferences
Events
Resources
Subscribe

Opinion|Videos|May 29, 2024

Newer Combinations for the Treatment of CLL

Author(s)Yuliya P.L Linhares, MD, Josie Montegaard, MSN, AGPCNP-BC

Dr Linhares discusses newer combination therapies for the treatment of patients with chronic lymphocytic leukemia, highlighting ibrutinib and venetoclax, which is being studied in the CAPTIVATE trial.

Episodes in this series

Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL

EP. 1 Understanding a CLL Diagnosis

Yuliya P.L Linhares, MD, an expert on CLL

EP. 2 Diagnostic Tests in CLL

Video 3 - "Goals of Treatment for Patients With CLL"

EP. 3 Goals of Treatment for Patients With CLL

Video 4 - "Current First-Line Treatment Options in CLL"

EP. 4 Current First-Line Treatment Options in CLL

Yuliya P.L Linhares, MD, an expert on CLL

EP. 5 Factors That Guide CLL Treatment Decisions

Josie Montegaard, MSN, AGPCNP-BC, an expert on CLL

EP. 6 What to Expect from Treatment

Video 7 - "Overview of Efficacy and Safety Data for Current CLL Treatment Options"

EP. 7 Overview of Efficacy and Safety Data for Current CLL Treatment Options

Video 8 - "Acalabrutinib-Based Treatment Clinical Trial Updates"

EP. 8 Acalabrutinib-Based Treatment Clinical Trial Updates

Yuliya P.L Linhares, MD, an expert on CLL

EP. 9 Venetoclax-Based Treatment Clinical Trial Updates

Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL

EP. 10 Zanubrutinib-Based Treatment Clinical Trial Updates

Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL

EP. 11 Ibrutinib-Based Treatment Clinical Trial Updates

Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL

EP. 12 Newer Combinations for the Treatment of CLL

Josie Montegaard, MSN, AGPCNP-BC, an expert on CLL

EP. 13 What to Know Before Starting Your CLL Treatment

Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL

EP. 14 An Overview of Potential Treatment Adverse Effects

Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL

EP. 15 Treatment Decisions in R/R CLL

Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL

EP. 16 Shared Decision-Making and Supportive Care in the CLL Treatment Journey

Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL

EP. 17 Optimizing Overall Health During CLL Management

Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL

EP. 18 Getting the Most From Your CLL Care Team

Newsletter

Stay up to date on cancer updates, research and education

Related Content

CLL

Jaypirca Matches Imbruvica's Effectiveness for CLL, With Hints of Long-Term Benefit

ByJason M Broderick

December 7th 2025

fda approved

FDA Approves Jaypirca for Relapsed/Refractory CLL or SLL

December 3rd 2025

Image of andy.

A Season to be Grateful as a Cancer Survivor

ByAndy Winnegar

November 17th 2025

Image of chester.

Living With Leukemia Chester Freeman Embraces Wabi-Sabi

ByChester Freeman

October 30th 2025

After surviving prostate cancer, Andy Winnegar received a diagnosis of chronic lymphocytic leukemia (CLL) in 2021. Catch up on Andy's blogs here!

How Can We Stand Up to Cancer as Patients?

ByAndy Winnegar

August 26th 2025

Trending on CURE

KRd Improves Progression in Newly Diagnosed Patients With Myeloma

Every FDA Oncology Approval From November 2025

Reflecting on My Sister’s Final Days After Years of Unexpected Rebounds

Elrexfio Maintains Responses in Elderly, Frail Patients With Multiple Myeloma

First Annual Blood Cancer Heroes Honors Leaders, Advocates and Survivors

© 2025 MJH Life Sciences^®

All rights reserved.